LiLash maker hid serum side effects behind 'cosmetic' label, a new class action lawsuit claims - Claim Depot
LiLash maker hid serum side effects behind 'cosmetic' label, a new class action lawsuit claims - Claim Depot — regulatory update affecting Cosmetics & Personal-Care (MoCRA).
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on September 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Cosmetics & Personal-Care (MoCRA) (private-label makers) should confirm how it applies to their specific situation before acting. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Cosmetics & Personal-Care (MoCRA) move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.
What changed
LiLash maker hid serum side effects behind 'cosmetic' label, a new class action lawsuit claims - Claim Depot
Who it affects
Cosmetics & Personal-Care (MoCRA) (private-label makers)
What you must do
Note this update; no immediate action appears required, but monitor for follow-on rules.
Deadline
No fixed deadline was published, but changes like this are often enforced quickly — act promptly.
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- Latest Updates on Per- and Polyfluorinated Substances (PFAS) – August update - The National Law Review
- FDA Issues Final Guidance on Facility Registration and Product Listing Under MoCRA - crowell.com
- Agency Information Collection Activities; Proposed Collection; Comment Request; Pregnancy Exposure Registry Enrollment Project: A Survey of Health Care Providers To Advance Pregnancy Safety Data Collection and Improve Health Communications
- Determination of Regulatory Review Period for Purposes of Patent Extension; ANDEMBRY
- Agency Information Collection Activities; Proposed Collection; Comment Request; Human Cells, Tissues, and Cellular and Tissue-Based Products